ROTTERDAM, Netherlands and SAN DIEGO, March 17, 2020 /PRNewswire/ -- SkylineDx shares research showing that multiple myeloma (blood cancer) patients...
News
Myeloma and the Coronavirus
With rising community concern about the novel coronavirus or COVID-19, Myeloma Australia would like to provide the following information sheet...
New CAR T-cell Therapy Shows Early Promise Against Multiple Myeloma in Lab Study
A new CAR T-cell therapy for people with multiple myeloma has been successfully created and tested in cell-based experiments and a mouse model, a...
Organ responses with daratumumab therapy in previously treated AL amyloidosis
Immunoglobulin light chain amyloidosis (AL amyloidosis) involves deposition of abnormally folded light chains into a wide range of tissues causing...
Sanofi Partners to Develop Diagnostic Test for Multiple Myeloma Patients on Potential Therapy
Sanofi announced that it partnered with Sebia to develop a new multiple myeloma diagnostic test that will help to mitigate the interference of...
ALCYONE Update: Adding Daratumumab to VMP Improves Survival in Transplant-Ineligible Myeloma
In patients with newly diagnosed multiple myeloma (MM) who are ineligible for high-dose chemotherapy and transplantation, adding daratumumab to...
Cancer drug funding welcomed
Mark Wellington cherished the final years he spent with his wife after she was diagnosed with multiple myeloma. Now he wants Pharmac to make good on...
Myeloma NZ calls on Pharmac to make good on access deal
Myeloma New Zealand is today calling on Pharmac to make good on their proposal to widen access to blood cancer treatment lenalidomide (Revlimid)...
Pharmac to widen treatment access for myeloma – New Zealand’s second most common blood cancer
Media Release In a move welcomed by patient advocacy group Myeloma New Zealand, drug buying agency Pharmac has proposed to widen access to blood...
Drug Previously Thought to Treat Alzheimer Shows Potential in Multiple Myeloma
Results from a new study at Hutchinson Cancer Research Cancer in Seattle suggests that chimeric antigen receptor (CAR) T-cell therapy can be further...
Cancer Control Agency open, Prime Minister hails Blair Vining’s ‘tireless advocacy’
The Prime Minister has acknowledged Blair Vining's "tireless advocacy" as the new independent Cancer Control Agency was formally opened on Tuesday....
Major developments in multiple myeloma to be presented at ASH
Starting Saturday, December 7, HemOnc Today will be onsite in Orlando at the ASH Annual Meeting and Exposition, bringing the latest in important,...